Cvs Health (CVS) Receivables (2009 - 2026)

Cvs Health (CVS) has reported Receivables for 18 consecutive years, with $53.3 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables rose 4.26% year-over-year to $53.3 billion; the trailing twelve-month figure through Jun 2026 stood at $53.3 billion (up 4.26% YoY), and the FY2025 full-year result was $50.3 billion, up 8.61% from the prior year.
• Receivables was little changed at $53.3 billion in Q2 2026 per CVS's latest filing, from $53.5 billion in the prior quarter.
• Across five years, Receivables topped out at $55.1 billion in Q3 2025 and bottomed at $34.3 billion in Q3 2022.
• Historically, Receivables has averaged $44.5 billion across 5 years, with a median of $44.7 billion in 2023.
• The sharpest annual moves came in 2023 and 2024: Receivables increased 30.0% in 2023, then slipped 1.67% in 2024.
• Over 5 years, Receivables stood at $36.3 billion in 2022, then climbed by 30.0% to $47.1 billion in 2023, then retreated by 1.67% to $46.4 billion in 2024, then rose by 8.61% to $50.3 billion in 2025, then gained by 5.86% to $53.3 billion in 2026.
• According to Business Quant data, Receivables over the past three periods registered $53.3 billion, $53.5 billion, and $50.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.